DE69816051D1 - Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien - Google Patents

Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien

Info

Publication number
DE69816051D1
DE69816051D1 DE69816051T DE69816051T DE69816051D1 DE 69816051 D1 DE69816051 D1 DE 69816051D1 DE 69816051 T DE69816051 T DE 69816051T DE 69816051 T DE69816051 T DE 69816051T DE 69816051 D1 DE69816051 D1 DE 69816051D1
Authority
DE
Germany
Prior art keywords
compositions
methods
biological reagent
biological reagents
inhibiting light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816051T
Other languages
English (en)
Other versions
DE69816051T2 (de
Inventor
F Beuchler
H Mcpherson
R Sundquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere San Diego Inc
Original Assignee
Biosite Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite Diagnostics Inc filed Critical Biosite Diagnostics Inc
Publication of DE69816051D1 publication Critical patent/DE69816051D1/de
Application granted granted Critical
Publication of DE69816051T2 publication Critical patent/DE69816051T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/13—Tracers or tags
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving
DE69816051T 1997-04-09 1998-04-06 Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien Expired - Lifetime DE69816051T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/837,309 US6544797B1 (en) 1997-04-09 1997-04-09 Compositions and methods for inhibiting light-induced inactivation of biological reagents
US837309 1997-04-09
PCT/US1998/006793 WO1998045705A2 (en) 1997-04-09 1998-04-06 Compositions and methods for inhibiting light-induced inactivation of biological reagents

Publications (2)

Publication Number Publication Date
DE69816051D1 true DE69816051D1 (de) 2003-08-07
DE69816051T2 DE69816051T2 (de) 2004-05-19

Family

ID=25274130

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816051T Expired - Lifetime DE69816051T2 (de) 1997-04-09 1998-04-06 Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien

Country Status (8)

Country Link
US (2) US6544797B1 (de)
EP (1) EP0972194B1 (de)
JP (1) JP2001519908A (de)
AT (1) ATE244404T1 (de)
AU (1) AU6796598A (de)
CA (1) CA2286183C (de)
DE (1) DE69816051T2 (de)
WO (1) WO1998045705A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799839A1 (fr) * 2000-02-02 2001-04-20 Commissariat Energie Atomique Procede pour determiner la capacite antioxydante de composes chimiques et procedes de dosage et d'immobilisation utilisables pour cette determination
US6800068B1 (en) * 2001-10-26 2004-10-05 Radiant Medical, Inc. Intra-aortic balloon counterpulsation with concurrent hypothermia
US11008359B2 (en) 2002-08-23 2021-05-18 Illumina Cambridge Limited Labelled nucleotides
US20040241880A1 (en) * 2003-05-30 2004-12-02 Leproust Eric M. Ligand array assays having reduced fluorescent dye degradation and compositions for practicing the same
US20040241742A1 (en) * 2003-05-30 2004-12-02 Peck Bill J. Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same
GB0424294D0 (en) * 2004-11-03 2004-12-01 Elam T Ltd Buffer layer
EP1828412B2 (de) * 2004-12-13 2019-01-09 Illumina Cambridge Limited Verbessertes nukleotidnachweisverfahren
GB0427236D0 (en) 2004-12-13 2005-01-12 Solexa Ltd Improved method of nucleotide detection
US7998717B2 (en) 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20100311186A1 (en) * 2006-07-28 2010-12-09 Biosite Incorporated Devices and methods for performing receptor binding assays using magnetic particles
US20090043109A1 (en) * 2007-08-07 2009-02-12 Spangler Brenda D Asymmetric one- and two-photon fluorophores for simultaneous detection of multiple analytes using a common excitation source
US20090062386A1 (en) * 2007-08-30 2009-03-05 Clean Earth Technologies, Llc Simulants of Toxants for Training and Testing
US20090057622A1 (en) * 2007-08-31 2009-03-05 Clean Earth Technologies, Llc Simulant of Radiological Contamination
EP2252625B1 (de) * 2008-02-07 2017-12-20 Pacific Biosciences of California, Inc. In linker eingebundene, cis-reaktive sauerstoffquencher
WO2009114182A1 (en) 2008-03-13 2009-09-17 Pacific Biosciences Of California, Inc. Labeled reactants and their uses
US8388982B2 (en) * 2008-11-19 2013-03-05 Pacific Biosciences Of California, Inc. Photo-induced damage mitigating agents and preparation and methods of use thereof
DE102009010563A1 (de) 2009-02-16 2010-08-26 Matthias W. Engel Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
GB0913258D0 (en) 2009-07-29 2009-09-02 Dynex Technologies Inc Reagent dispenser
US9523701B2 (en) 2009-07-29 2016-12-20 Dynex Technologies, Inc. Sample plate systems and methods
WO2012021733A2 (en) 2010-08-12 2012-02-16 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
US8906612B2 (en) 2010-08-25 2014-12-09 Pacific Biosciences Of California, Inc. Scaffold-based polymerase enzyme substrates
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
US8835000B2 (en) * 2011-12-23 2014-09-16 General Electric Company High-density fluorescent dye clusters
DE102012102082B3 (de) * 2012-03-13 2013-03-21 Thyssenkrupp Rasselstein Gmbh Verfahren zur Behandlung eines mit einer Metallbeschichtung versehenen Stahlbands oder -blechs mit einem Nachbehandlungsmittel sowie ein mit einer Metallbeschichtung versehenes Stahlband oder -blech.
US9315864B2 (en) 2012-05-18 2016-04-19 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes with sulfonic acid substituents
US10458915B2 (en) 2012-05-18 2019-10-29 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
US20140072959A1 (en) 2012-09-12 2014-03-13 Force Diagnostics, Inc. Rapid tests for insurance underwriting
CN105051542A (zh) * 2012-10-31 2015-11-11 阿斯图德医疗有限公司 定量的侧向流测定法
CN105102980B (zh) 2013-02-26 2017-11-03 阿斯图特医药公司 具有试条保持件的横向流动测定法
CN108864232B (zh) 2013-03-15 2022-01-04 伊鲁米纳剑桥有限公司 修饰的核苷或核苷酸
CN108051590B (zh) 2013-09-13 2020-12-11 Symbolics有限责任公司 运用二维试验和对照信号读出模式的侧向层析检测
JP6286966B2 (ja) * 2013-09-18 2018-03-07 コニカミノルタ株式会社 蛍光標識用樹脂粒子およびその製造方法、並びに、これを含む免疫染色用蛍光標識剤
US20180106799A1 (en) 2015-04-06 2018-04-19 Bludiagnostics, Inc. A test device for detecting an analyte in a saliva sample and method of use
EP3676612A4 (de) * 2017-08-31 2021-05-26 Agilent Technologies, Inc. Zusammensetzung zur stabilisierung von percp enthaltenden antikörperformulierungen
US20200363406A1 (en) * 2017-10-26 2020-11-19 The University Of Houston System Highly-specific assays
WO2021213321A1 (en) 2020-04-20 2021-10-28 Mgi Tech Co., Ltd. Dna protection agent in dna imaging buffer

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283382A (en) 1977-12-28 1981-08-11 Eastman Kodak Company Fluorescent labels comprising rare earth chelates
US4351760A (en) 1979-09-07 1982-09-28 Syva Company Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
US4420568A (en) 1980-07-30 1983-12-13 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins
US5075215A (en) 1984-06-11 1991-12-24 Dreyer William J Use of daylight fluorescent pigments for tagging biological molecules
US4868132A (en) 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US4876190A (en) 1987-10-21 1989-10-24 Becton Dickinson & Company Peridinin-chlorophyll complex as fluorescent label
DE3919393A1 (de) * 1989-06-14 1990-12-20 Hoechst Ag Verfahren zur stabilisierung von auf festphasen immobilisierten biologisch aktiven substanzen
DE4004296A1 (de) * 1990-02-13 1991-08-14 Hoechst Ag Verbesserte markierte haptene, verfahren zu deren herstellung sowie verwendung dieser markierten haptene in immunoassays
US5747334A (en) * 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5227487A (en) * 1990-04-16 1993-07-13 Molecular Probes, Inc. Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
DE69132750T2 (de) * 1990-05-15 2002-06-20 Hyperion Inc Fluoreszierende porphyrin- und fluoreszierende phthalocyanin-polyethylenglykol-, polyol- und saccharidderivate als fluoreszierende sonden
DE69125992T2 (de) * 1990-09-14 1997-08-21 Tosoh Corp Verfahren und Kit für Immunoassay
ATE177841T1 (de) * 1991-04-10 1999-04-15 Biosite Diagnostics Inc ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung
US5230836A (en) * 1991-06-20 1993-07-27 Kalamazoo Holdings, Inc. Low micron-sized ascorbic acid particles, especially a suspension thereof in a medium in which they are insoluble, and the use thereof as an antioxidant for mediums in which the particles remain insoluble
ATE162892T1 (de) * 1992-07-31 1998-02-15 Behringwerke Ag Photoaktivierbare chemiluminizierende matrices
US6251687B1 (en) * 1993-09-24 2001-06-26 Biosite Diagnostics, Inc. Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
EP0796108A2 (de) * 1994-12-06 1997-09-24 Ryan Pharmaceuticals, Inc. Wasser-lösliche ubiquinone-zusammensetzungen, prodroge, und verfahren dembezüglich
US5650512A (en) * 1995-06-07 1997-07-22 Systemix Fluorescent labeling reagents
US5798276A (en) * 1995-06-07 1998-08-25 Molecular Probes, Inc. Reactive derivatives of sulforhodamine 101 with enhanced hydrolytic stability

Also Published As

Publication number Publication date
JP2001519908A (ja) 2001-10-23
ATE244404T1 (de) 2003-07-15
CA2286183C (en) 2008-11-18
US7588908B2 (en) 2009-09-15
EP0972194A2 (de) 2000-01-19
US6544797B1 (en) 2003-04-08
WO1998045705A3 (en) 1998-12-30
US20030129642A1 (en) 2003-07-10
CA2286183A1 (en) 1998-10-15
EP0972194B1 (de) 2003-07-02
AU6796598A (en) 1998-10-30
WO1998045705A2 (en) 1998-10-15
DE69816051T2 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
ATE244404T1 (de) Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien
ATE299145T1 (de) Neues multimerisierendes reagenz
DE69218101D1 (de) Monofluorierte Derivate von N-Propargyl-1-Aminoindan und deren Verwendung als Monoamino-Oxidaseinhibitoren
ATE261310T1 (de) Nicht-antigene von aminen abgeleitete polymere und polymerkonjugate
ATE222254T1 (de) Verwendung von einem metalloporphyrinkonjugat für den nachweis biologischer verbindungen
DE69941333D1 (de) Molekulare fackeln
CY1106984T1 (el) Νεα βιοσυγκολλητικη συνθεση που περιεχει μια βιοσυγκολλητικη πολυφαινολικη πρωτεϊνη, ενα πολυμερες που περιεχει ομαδες υδατανθρακα, φαρμακευτικως αποδεκτα λεπτα νηματα και οι χρησεις τους
DE69607830D1 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
BR0016197A (pt) Sistema catalisador múltiplo
DE69637256D1 (de) Synthese von Methoxynukleoside und enzymatische Nukleisäure Moleküle
BR9808491A (pt) Compostos calcilìticos
PT842934E (pt) Agonistas de 5-ht1f
DE69819360D1 (de) Neue psoralene zur inaktivierung von pathogenen
ATE208827T1 (de) Konjugate von dns und pns und verfahren zu deren herstellung
ATE495240T1 (de) Ligand des zelleintritt-vermittelnden proteins von herpes simplex virus und methoden zu dessen verwendung
FI925988A (fi) Foerfarande foer framstaellning av b-laktamer
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
FR2774097B1 (fr) Utilisation de derives d'indolamine dans la detection d'une activite de peptidase ou dans la detection de micro-organismes
ATE240953T1 (de) Carbazolcarboxamide als 5-ht1f agonisten
BR9908799A (pt) Poli (etileno tereftalato) e polìmero de poli (alquileno arilato).
BR9814188A (pt) "agonistas de 5-ht1f"
DE69601640D1 (de) Microbiologischer abbau von alkylenen aminoessigsäuren
IT1291320B1 (it) Procedimento per la preparazione di composti aromatici contenenti un sistema eterociclico
FI963055A (fi) Kondensaatio- ja additiopolymeereja, jotka sisältävät N,N'-sillan sisältäviä bis(tetrametyylipiperidinyylioksi)-ryhmiä
DK1012156T3 (da) Nukleinsyresekvenser og fremgangsmåde til påvisning af bakterier af slægten Pseudomonas aeruginosa

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BIOSITE INCORPORATED, SAN DIEGO, CALIF., US

8364 No opposition during term of opposition